Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Metastatic Malignant Neoplasm to Brain
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This research study is studying palbociclib as a possible treatment for recurrent brain metastases. - Pfizer, a pharmaceutical company, is supporting this research study by providing the study drug as well as funding for research activities

Provided treatments

  • Drug: Palbociclib
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02896335. The sponsor of the trial is Massachusetts General Hospital and it is looking for 30 volunteers for the current phase.
Official trial title:
A Phase 2 Study of Palbociclib in Progressive Brain Metastases Harboring Alterations in the CDK Pathway